2018 prize winners

ACP McElwain Prize

Circulating tumour DNA as a tool to guide clinical decision making in melanoma

Rebecca Lee, The Christie NHS Foundation Trust, UK

 


AstraZeneca Young Scientist Poster Prize

BAP1 loss induces BRCA1 dependent and independent defective spindle organization, checkpoint dysfunction and genomic instability

Anita Singh, University of Leicester, UK

 


BACR – AstraZeneca Young Scientist Frank Rose Award

From rarity to clarity: gd T cells in cancer

Seth Coffelt, Beatson Institute for Cancer Research, UK

 


BACR – Astex Pharmaceuticals Roger Griffin Prize for Cancer Drug Discovery

Antibody Tumour Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment

Sean Lim, University of Southampton, UK

 


BACR Gordon Hamilton-Fairley Young Investigator Award

Targeting RSK4 prevents both chemoresistance and metastasis in lung cancer

Stelio Chysostomou, Imperial College London, UK

Effective chemoprevention strategies in APC driven mouse models of intestinal tumourigenesis

Michael Hodder, CRUK Beatson Institute, UK

 


Children’s Cancer and Leukaemia Group (CCLG) Award

Polyphenols Act Synergistically with Doxorubicin and Etoposide in Leukemia Cell Lines

Amani Mahbub, Faculty of Applied Medical Sciences – Umm Al Qura University, Saudi Arabia

 


The Company of Biologists Travel Awards

A novel cis-acting lncRNA controls HMGA1 expression and is deregulated in non-small cell lung cancer

Greg Stewart, BC Cancer Research Centre, Canada

Salivary melatonin and squamous cell carcinoma antigen 1 levels in patients with oral squamous cell carcinoma

Ivan Salarić, University Hospital Dubrava, Croatia

Cholangiocarcinoma survival prediction using machine learning algorithms

Mohamed Osman, Zagazig University, Egypt

Glycolysis supports EGFR-mutant Lung Adenocarcinoma Cell Survival by blocking Autophagy-mediated EGFR Degradation

Wonjun Ji, Asan Medical Center, South Korea

 


CREST Awards

Amy Burger, Queen Elizabeth Hospital Kings Lynn NHS Trust, UK

Angela Bloss, Oxford University Hospitals NHS Foundation Trust, UK

Angela Holford, Queen Elizabeth Hospital Kings Lynn NHS Trust, UK

Lony Evans, Oxford University Hospitals NHS Foundation Trust, UK

Saloni Mittal, Queen Elizabeth Hospital Birmingham, UK

Sharon Garner, Queen Elizabeth Hospital Birmingham, UK

 


Cancer Research UK Prizes

Jamie Brown, University College London, UK

Rebecca Fitzgerald, University of Cambridge, UK

Sarah Bohndiek, University of Cambridge, UK

Vivian Li, The Francis Crick Institute, UK

 


Cancer Research UK Lifetime Achievement Award

Chromosome breakage and inheritable cancers

Stephen West, The Francis Crick Institute, UK

 


NCRI Bursary Prize

Cisplatin-induced kidney injury is transient and associated with short-term elevation of urine interleukin-18 in patients with testicular cancer

Alan Cameron, University of Glasgow, UK

 

Young colorectal cancer patients experience referral delays in primary care leading to emergency diagnoses

Delays in primary care are associated with a late stage and worse prognosis for colorectal cancer patients: A population based study

Chanpreet Arhi, Imperial College London, UK

 

Trends in mortality from malignant melanoma: an observational study of the World Health Organisation mortality database from 1985 to 2015

Dorothy Yang, Royal Free London NHS Foundation Trust, UK

 

Endoglin expression on cancer-associated fibroblasts regulates invasion and stimulates colorectal cancer metastasis

Madelon Paauwe, Beatson Institute for Cancer Research, UK

 

Defining microRNA mediated regulation of CD157 involved in colon cancer progression

Mahnaz Darvish Damavandi, The Institute of Cancer Research, UK

 

Investigating the effects of dietary and physical activity interventions on the metabolome of men with prostate cancer: The PrEvENT randomised controlled trial

Meda Sandu, University of Bristol, UK

 

The role of translational elongation loss in colorectal cancer

Nikola Vlahov, The Beatson Institute for Cancer Research, UK

 

Embedding patient voice in cancer service improvement: A qualitative study of patients’ experience of the NHS cancer diagnostic care pathway

Sarah Sowden, Newcastle University, UK

 

Defining DDR deficiency and replication stress in pancreatic cancer

Stephan Dreyer, University of Glasgow, UK

 


NCRI Werth Trust Award

Molecular mechanisms underlying phenotypic plasticity in malignant glioma

Costanza Lo Cascio, Barrow Neurological Institute, USA

 


Royal College of Radiologists (RCR) Oral Ross Award Prize

FOS/FOSB rearrangements; defining the human bone tumour, osteoblastoma

Matthew Fittal, The Francis Crick Institute, UK

 


Royal College of Radiologists (RCR) Poster Ross Award Prize

Is there a role for a biological boost in squamous cell anal cancer?

Ahmad Sabbagh, Oxford University Hospitals Trust, UK